TSN Stock Analysis: Tyson Foods | NYSE
Farm Products | NYSE, USA | Market Cap: 21.929m USD | 12M Return: 24.6% | US9024941034 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 231M
EPS Trend: 76.5%
Qual. Beats: 0
Rev. Trend: 97.3%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Tyson Foods (NYSE: TSN) is a U.S.-headquartered, multinational food company that operates across four core segments: Beef, Pork, Chicken, and Prepared Foods. The company runs a vertically integrated protein business, processing live cattle and hogs into primal and sub-primal cuts and ready-to-cook meats, raising and processing chickens into fresh, frozen, and value-added poultry products, and producing a broad portfolio of branded refrigerated and frozen foods such as sandwiches, bacon, sausage, lunchmeats, hot dogs, and ethnic or snack items. Its portfolio includes well-known consumer brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, Gallo Salame, ibp, and State Fair.
The company distributes through a multi-channel network spanning grocery retailers and wholesalers, warehouse clubs, military commissaries, chain restaurants and their distributors, international exporters, food-service operators (such as schools, hospitals, and convenience stores), and independent brokers. Founded in 1935, Tyson is based in Springdale, Arkansas, and is classified within the Consumer Staples sector under the Packaged Foods & Meats sub-industry. As one of the largest protein producers in the United States, Tyson benefits from scale advantages in livestock sourcing, processing capacity, and refrigerated supply-chain logistics, and its diversified mix of commodity meat production and higher-margin prepared foods helps balance exposure to volatile input costs and shifting consumer protein preferences.
- Beef segment margins compress on elevated cattle costs
- Chicken pricing recovers as feed costs ease
- Prepared Foods revenue grows on Jimmy Dean and Hillshire demand
| Net Income: 453.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.53 > 1.0 |
| NWC/Revenue: 5.48% < 20% (prev 6.48%; Δ -1.00% < -1%) |
| CFO/TA 0.07 > 3% & CFO 2.43b > Net Income 453.0m |
| Net Debt (6.93b) to EBITDA (2.46b): 2.81 < 3 |
| Current Ratio: 1.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (121.3m) vs 12m ago -57.73% < -2% |
| Gross Margin: 5.73% > 18% (prev 6.54%; Δ -0.82% > 0.5%) |
| Asset Turnover: 157.2% > 50% (prev 148.5%; Δ 8.72% > 0%) |
| Interest Coverage Ratio: 2.62 > 6 (EBIT TTM 1.06b / Interest Expense TTM 406.0m) |
| A: 0.09 (Total Current Assets 9.32b - Total Current Liabilities 6.23b) / Total Assets 35.1b |
| B: 0.52 (Retained Earnings 18.4b / Total Assets 35.1b) |
| C: 0.03 (EBIT TTM 1.06b / Avg Total Assets 35.9b) |
| D: 2.02 (Book Value of Equity 35.3b / Total Liabilities 17.5b) |
| Altman-Z'' = 4.61 = AA |
| DSRI: 0.90 (Receivables 2.37b/2.52b, Revenue 56.4b/54.4b) |
| GMI: 1.14 (GM 6.54% / 5.73%) |
| AQI: 1.03 (AQ_t 0.49 / AQ_t-1 0.48) |
| SGI: 1.04 (Revenue 56.4b / 54.4b) |
| TATA: -0.06 (NI 453.0m - CFO 2.43b) / TA 35.1b) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of November 20, 2026, the stock is trading at USD 63.86 with a total of 3,326,351 shares traded. Over the past week, the price has changed by +7.76%, over one month by +18.26%, over three months by +10.09% and over the past year by +24.61%.
Current recommended Stop Loss: 60.80 (which is 4.8% or 1.7 ATR below the current price).
Tyson Foods has received a consensus analysts rating of 3.46. Therefore, it is recommended to hold TSN.
- StrongBuy: 2
- Buy: 3
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 67.1 | 5.1% |
P/E Trailing = 49.7266
P/E Forward = 15.625
P/S = 0.3887
P/B = 1.2509
P/EG = 1.0438
Revenue TTM = 56.4b USD
EBIT TTM = 1.06b USD
EBITDA TTM = 2.46b USD
Long Term Debt = 6.90b USD (from longTermDebt, last quarter)
Short Term Debt = 848.0m USD (from shortTermDebt, last quarter)
Debt = 7.75b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.93b USD (calculated: Debt 7.75b - CCE 824.0m)
Enterprise Value = 28.9b USD (21.9b + Debt 7.75b - CCE 824.0m)
Interest Coverage Ratio = 2.62 (Ebit TTM 1.06b / Interest Expense TTM 406.0m)
EV/FCF = 17.35x (Enterprise Value 28.9b / FCF TTM 1.66b)
FCF Yield = 5.76% (FCF TTM 1.66b / Enterprise Value 28.9b)
FCF Margin = 2.95% (FCF TTM 1.66b / Revenue TTM 56.4b)
Net Margin = 0.80% (Net Income TTM 453.0m / Revenue TTM 56.4b)
Gross Margin = 5.73% ((Revenue TTM 56.4b - Cost of Revenue TTM 53.2b) / Revenue TTM)
Gross Margin QoQ = 3.70% (prev 6.64%)
Tobins Q-Ratio = 0.82 (Enterprise Value 28.9b / Total Assets 35.1b)
Interest Expense / Debt = 5.24% (Interest Expense 406.0m / Debt 7.75b)
Taxrate = 29.30% (196.0m / 669.0m)
NOPAT = 753.0m (EBIT 1.06b * (1 - 29.30%))
Current Ratio = 1.50 (Total Current Assets 9.32b / Total Current Liabilities 6.23b)
Debt / Equity = 0.22 (Debt 7.75b / totalStockholderEquity, last quarter 35.3b)
Debt / EBITDA = 2.81 (Net Debt 6.93b / EBITDA 2.46b)
Debt / FCF = 4.16 (Net Debt 6.93b / FCF TTM 1.66b)
Total Stockholder Equity = 22.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.26% (Net Income 453.0m / Total Assets 35.1b)
RoE = 2.02% (Net Income TTM 453.0m / Total Stockholder Equity 22.4b)
RoCE = 3.64% (EBIT 1.06b / Capital Employed (Equity 22.4b + L.T.Debt 6.90b))
RoIC = 2.61% (NOPAT 753.0m / Invested Capital 28.9b)
WACC = 4.76% (E(21.9b)/V(29.7b) * Re(5.14%) + D(7.75b)/V(29.7b) * Rd(5.24%) * (1-Tc(0.29)))
Discount Rate = 5.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -32.00 | Cagr: -31.69%
[DCF] Terminal Value 77.97% ; FCFF base≈1.47b ; Y1≈1.68b ; Y5≈2.48b
[DCF] Fair Price = 110.6 (EV 37.3b - Net Debt 6.93b = Equity 30.4b / Shares 274.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 76.54 | EPS CAGR: 38.91% | SUE: -0.33 | # QB: 0
Revenue Correlation: 97.32 | Revenue CAGR: 2.45% | SUE: 1.15 | # QB: 1
EPS current Quarter (2026-12-31): EPS=0.84 | Chg30d=-16.22% | Revisions=-50% | Analysts=6
EPS next Quarter (2027-03-31): EPS=0.79 | Chg30d=-17.35% | Revisions=+17% | Analysts=6
EPS current Year (2027-09-30): EPS=3.57 | Chg30d=-12.44% | Revisions=-57% | GrowthEPS=+3.8% | GrowthRev=-5.2%
EPS next Year (2028-09-30): EPS=4.75 | Chg30d=-4.73% | Revisions=-50% | GrowthEPS=+33.2% | GrowthRev=+2.5%
[Analyst] Revisions Ratio: -56% (up=2, down=11)